The SILVER (silver impregnated line versus evd randomized trial): A double-blind, prospective, randomized, controlled trial of an intervention to reduce the rate of external ventricular drain infection

Neurosurgery

Volumn 71, Issue 2, 2012, Pages 394-403

  Keong, Nicole Chwee Har ^a   Bulters, Diederik Olivier ^b   Richards, Hugh K ^a   Farrington, Mark ^c   Sparrow, Owen C ^b   Pickard, John D ^a   Hutchinson, Peter J ^a   Kirkpatrick, Peter J ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Catheter; Cerebrospinal fluid; External ventricular drain; Infection; Multi institutional study

Indexed keywords

ACINETOBACTER; ADULT; AGED; ARTICLE; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; BRAIN VENTRICLE PERITONEUM SHUNT; CANDIDA; CATHETER; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CULTURE; CEREBROSPINAL FLUID DRAINAGE; CEREBROSPINAL FLUID INFECTION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENTEROCOCCUS; FEMALE; HUMAN; HYDROCEPHALUS; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SERRATIA; SILVER IMPREGNATION; STAPHYLOCOCCUS; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CEREBRAL VENTRICLES; CEREBROSPINAL FLUID SHUNTS; COATED MATERIALS, BIOCOMPATIBLE; COMORBIDITY; DOUBLE-BLIND METHOD; DRAINAGE; ENCEPHALITIS; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS; SILVER; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864281361     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e318257bebb     Document Type: Article

References (31)

1. Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES Jr. Ventriculostomy- related infections: a critical review of the literature. Neurosurgery. 2002;51(1):170-181; discussion 181-182.
2. Korinek AM, Reina M, Boch AL, Rivera AO, De Bels D, Puybasset L. Prevention of external ventricular drain-related ventriculitis. Acta Neurochir (Wien). 2005;147 (1):39-45; discussion 45-46.
3. Beer R, Lackner P, Pfausler B, Schmutzhard E. Nosocomial ventriculitis and meningitis in neurocritical care patients. J Neurol. 2008;255(11):1617-1624.
4. van de Beek D, Drake JM, Tunkel AR. Nosocomial bacterial meningitis. N Engl J Med. 2010;362(2):146-154.
5. Hoefnagel D, Dammers R, Ter Laak-Poort MP, Avezaat CJ. Risk factors for infections related to external ventricular drainage. Acta Neurochir (Wien). 2008; 150(3):209-214; discussion 214.
6. Williams TA, Leslie GD, Dobb GJ, Roberts B, van Heerden PV. Decrease in proven ventriculitis by reducing the frequency of cerebrospinal fluid sampling from extraventricular drains. J Neurosurg. 2011;115(5):1040-1046.
7. Dasic D, Hanna SJ, Bojanic S, Kerr RS. External ventricular drain infection: the effect of a strict protocol on infection rates and a review of the literature. Br J Neurosurg. 2006;20(5):296-300.
8. Wong GK, Poon WS,Wai S, Yu LM, Lyon D, Lam JM. Failure of regular external ventricular drain exchange to reduce cerebrospinal fluid infection: result of a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2002;73(6):759-761.
9. Blomstedt GC. Results of trimethoprim-sulfamethoxazole prophylaxis in ventriculostomy and shunting procedures. A double-blind randomized trial. J Neurosurg. 1985;62(5):694-697.
10. Wyler AR, KellyWA. Use of antibiotics with external ventriculostomies. J Neurosurg. 1972;37(2):185-187.
11. Alleyne CH Jr, Hassan M, Zabramski JM. The efficacy and cost of prophylactic and perioprocedural antibiotics in patients with external ventricular drains. Neurosurgery. 2000;47(5):1124-1127; discussion 1127-1129.
12. Poon WS, Ng S,Wai S. CSF antibiotic prophylaxis for neurosurgical patients with ventriculostomy: a randomised study. Acta Neurochir Suppl. 1998;71:146-148.
13. Wong GK, Ip M, Poon WS, Mak CW, Ng RY. Antibiotics-impregnated ventricular catheter versus systemic antibiotics for prevention of nosocomial CSF and non-CSF infections: a prospective randomized clinical trial. J Neurol Neurosurg Psychiatry. 2010;81(10):1064-1067.
14. Zabramski JM, Whiting D, Darouiche RO, et al. Efficacy of antimicrobialimpregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg. 2003;98(4):725-730.
15. Abla AA, Zabramski JM, Jahnke HK, Fusco D, Nakaji P. Comparison of two antibiotic-impregnated ventricular catheters: a prospective sequential series trial. Neurosurgery. 2011;68(2):437-442; discussion 442.
16. ATSDR. Toxicological Profile for Silver. TP-90-24. Atlanta, GA: Agency for Toxic Substances and Disease Registry; 1990.
17. Furst A, Schlauder MC. Inactivity of two noble metals as carcinogens. J Environ Pathol Toxicol. 1978;1(1):51-57.
18. Lansdown AB. Critical observations on the neurotoxicity of silver. Crit Rev Toxicol. 2007;37(3):237-250.
19. Galiano K, Pleifer C, Engelhardt K, et al. Silver segregation and bacterial growth of intraventricular catheters impregnated with silver nanoparticles in cerebrospinal fluid drainages. Neurol Res. 2008;30(3):285-287.
20. WHO. Guidelines for Drinking-water Quality. 3rd ed. Geneva, Switzerland: WHO; 2006. Available at: http://www.who.int/water-sanitation-health.
21. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antisepticimpregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA. 1999;281(3):261-267.
22. Brosnahan J, Jull A, Tracy C. Types of urethral catheters for management of shortterm voiding problems in hospitalised adults. Cochrane Database Syst Rev. 2004; (1):CD004013.
23. Rupp ME, Fitzgerald T, Marion N, et al. Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. Am J Infect Control. 2004; 32(8):445-450.
24. Samuel U, Guggenbichler JP. Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. Int J Antimicrob Agents. 2004; 23(suppl 1):S75-S78.
25. Bayston R, Vera L, Mills A, Ashraf W, Stevenson O, Howdle SM. In vitro antimicrobial activity of silver-processed catheters for neurosurgery. J Antimicrob Chemother. 2010;65(2):258-265.
26. Secer HI, Kural C, Kaplan M, et al. Comparison of the efficacies of antibioticimpregnated and silver-impregnated ventricular catheters on the prevention of infections. An in vitro laboratory study. Pediatr Neurosurg. 2008;44(6):444-447.
27. Schlesselman JJ. Sample size requirements in cohort and case-control studies of disease. Am J Epidemiol. 1974;99(6):381-384.
28. Lackner P, Beer R, Broessner G, et al. Efficacy of silver nanoparticles-impregnated external ventricular drain catheters in patients with acute occlusive hydrocephalus. Neurocrit Care. 2008;8(3):360-365.
29. Fichtner J, Guresir E, Seifert V, Raabe A. Efficacy of silver-bearing external ventricular drainage catheters: a retrospective analysis. J Neurosurg. 2010;112(4): 840-846.
30. Muttaiyah S, Ritchie S, Upton A, Roberts S. Clinical parameters do not predict infection in patients with external ventricular drains: a retrospective observational study of daily cerebrospinal fluid analysis. J Med Microbiol. 2008;57(Pt 2):207-209.
31. Meredith FT, Phillips HK, Reller LB. Clinical utility of broth cultures of cerebrospinal fluid from patients at risk for shunt infections. J Clin Microbiol. 1997;35(12):3109-3111.